Jaguar Health, Inc. (JAGX)

Jaguar Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	10.48	9.76	11.96	4.34	9.39	5.78
Revenue Growth (YoY)	-2.25%	-18.36%	175.80%	-53.81%	62.51%	30.77%
Cost of Revenue	2.09	2.04	2.02	2.33	3.16	3.82
Gross Profit	8.4	7.72	9.94	2	6.22	1.96
Selling, General & Admin	22.78	23.05	26.71	26	20	20.44
Research & Development	15.47	18.6	17.65	15.08	6.41	5.82
Operating Expenses	38.26	41.64	44.35	41.08	26.41	26.26
Operating Income	-29.86	-33.92	-34.42	-39.07	-20.19	-24.3
Interest Expense	-0.59	-6.38	-12.72	-8.42	-2.79	-5.73
Other Non Operating Income (Expenses)	-8.75	-4.93	0.93	-2.72	-2.51	1.09
EBT Excluding Unusual Items	-39.2	-45.23	-46.21	-50.21	-25.48	-28.94
Asset Writedown	-0.37	-0.37	-	-	-0.12	-4
Other Unusual Items	1.25	3.7	-2.19	-2.39	-8.21	-5.59
Pretax Income	-38.33	-41.9	-48.4	-52.6	-33.81	-38.53
Income Tax Expense	-	-	-	-	-	0.01
Earnings From Continuing Operations	-38.33	-41.9	-48.4	-52.6	-33.81	-38.54
Minority Interest in Earnings	0.58	0.6	0.94	0.01	-	-
Net Income	-37.74	-41.3	-47.45	-52.6	-33.81	-38.54
Preferred Dividends & Other Adjustments	-	-	-	-	4.84	6.19
Net Income to Common	-37.74	-41.3	-47.45	-52.6	-38.65	-44.73
Shares Outstanding (Basic)	0	0	-	-	-	-
Shares Outstanding (Diluted)	0	0	-	-	-	-
EPS (Basic)	-205.60	-2685.48	-	-	-	-
EPS (Diluted)	-205.60	-2685.48	-	-	-	-
Free Cash Flow	-29.03	-33.24	-33.18	-34.98	-15.29	-20.46
Free Cash Flow Per Share	-158.11	-2161.52	-	-	-	-
Gross Margin	80.11%	79.13%	83.11%	46.18%	66.31%	33.92%
Operating Margin	-284.92%	-347.50%	-287.85%	-901.36%	-215.09%	-420.76%
Profit Margin	-360.13%	-423.11%	-396.91%	-1213.26%	-411.81%	-774.48%
Free Cash Flow Margin	-276.96%	-340.56%	-277.53%	-806.83%	-162.87%	-354.23%
EBITDA	-27.94	-31.91	-32.43	-37.36	-18.46	-22.56
EBITDA Margin	-266.56%	-	-271.28%	-	-196.69%	-
D&A For EBITDA	1.92	2.01	1.98	1.72	1.73	1.74
EBIT	-29.86	-33.92	-34.42	-39.07	-20.19	-24.3
EBIT Margin	-284.92%	-	-287.85%	-	-215.09%	-
Revenue as Reported	0.72	-	-	4.34	-	5.78

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q